Table 5.
Associations between attitudes regarding information and healthcare and HPV vaccine hesitancy (VH1; VH2), expressed as odds ratios (ORs) with 95% confidence intervals (CIs).
| VH1*OR (95% CI) | VH2**OR (95% CI) | |
|---|---|---|
| General | ||
| Healthcare | 2.05 (1.55–2.70) | 4.53 (3.12–6.56) |
| Researchers | 3.26 (2.39–4.45) | 8.93 (6.15–12.97) |
| Politicians | 1.62 (1.33–1.98) | 2.35 (1.57–3.53) |
| School | 1.51 (1.23–1.85) | 2.46 (1.76–3.45) |
| Social insurance agency | 1.34 (1.10–1.63) | 1.71 (1.18–2.46) |
| Police | 1.44 (1.13–1.84) | 2.28 (1.57–3.31) |
| Regarding HPV–vaccine | ||
| Medical professionals | 6.16 (4.28–8.88) | 16.94 (11.53–24.88) |
| Regulatory institutions (LMV, SOS) | 4.56 (3.34–6.21) | 14.69 (10.18–21.19) |
| CAM | 0.67 (0.53–0.87) | 0.51 (0.35–0.76) |
| Social media | Inconclusive | Inconclusive |
| Other people | Inconclusive | Inconclusive |
| Own experiences | 1.39 (1.14–1.70) | 2.18 (1.55–3.06) |
| Evaluation of information | ||
| Source criticism | 1.57 (1.31–1.90) | inconclusive |
| Access to information | 3.72 (2.82–4.91) | 3.52 (1.91–6.49) |
| Easy to discern origin of information | 2.94 (2.17–3.98) | 3.85 (1.88–7.90) |
| Ability to assess quality and reliability of information | 3.05 (2.28–4.06) | 2.78 (1.53–5.07) |
| Having taken part in info/stories on risks associated with HPV-vaccine | ||
| From healthcare | Inconclusive | Inconclusive |
| From CAM | 1.83 (1.17–2.86) | 4.67 (2.75–7.92) |
| From other individuals | 1.39 (1.05–1.85) | 3.06 (2.06–4.53) |
| Never | 0.76 (0.62–0.93) | 0.43 (0.31–0.60) |
| Healthcare | ||
| Satisfied with healthcare | 1.67 (1.05–2.66) | 7.30 (3.22–16.56) |
| Vaccination | ||
| General vaccine hesitancy | 4.38 (3.59–5.34) | 11.54 (6.93–19.21) |
VH1 distinguishes between those reporting it to be very likely (no hesitancy) that they would let their daughter or son receive the HPV vaccine from those reporting it to be rather likely, rather unlikely, very unlikely, or that they did not know (hesitancy). This indicates some HPV vaccine hesitancy.
VH2 distinguishes between those reporting it to be very or rather likely (no hesitancy) that they would let their daughter receive the HPV vaccine from those reporting it to be rather or very unlikely, or that they did not know (hesitancy). This indicates more pronounced HPV vaccine hesitancy.